Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v14-FR
Language English French
Date Updated 2020-11-20 2020-11-19
Drug Identification Number 02465418 02465418
Brand name MAR-DILTIAZEM T MAR-DILTIAZEM T
Common or Proper name DILTIAZEM T DILTIAZEM T
Company Name MARCAN PHARMACEUTICALS INC MARCAN PHARMACEUTICALS INC
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 360MG 360MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 Tablet 100 Tablet
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-10-05 2020-10-05
Actual start date 2020-10-05 2020-10-05
Estimated end date 2020-11-19 2020-11-19
Actual end date 2020-11-19 2020-11-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments